Efficacy and Tolerability of Treatment With Alfalitic Plus Serenoa Repens Compared to Alfalitic Plus Antimuscarinic for Moderate-severe Lower Urinary Tract Symptoms

Clinical trial NCT07665749 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07665749
Sponsor: Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Status: NOT_YET_RECRUITING
Study type: OBSERVATIONAL

Benign Prostate Hypertrophy(BPH)

Start date: 2026-06-01
Primary completion: 2026-06-30
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.